---
title: "Linagliptin - Diabetes Mellitus, Type 2"
sidebar: mydoc_sidebar
permalink: db08882-mesh-d003924-1.html
toc: false 
---


Path ID: `DB08882_MESH_D003924_1`
{% include image.html url="images/db08882-mesh-d003924-1.png" file="db08882-mesh-d003924-1.png" alt="db08882-mesh-d003924-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D000069476">MESH:D000069476 </a> | Linagliptin | Drug |
| <a href="https://identifiers.org/UniProt:P27487">UniProt:P27487 </a> | Dipeptidyl peptidase 4 | Protein |
| <a href="https://identifiers.org/CHEBI:80270">CHEBI:80270 </a> | Glucagon-like peptide 1 | ChemicalSubstance |
| <a href="https://identifiers.org/UniProt:P09681">UniProt:P09681 </a> | Gastric inhibitory polypeptide | Protein |
| <a href="https://identifiers.org/GO:0030073">GO:0030073 </a> | insulin secretion | BiologicalProcess |
| <a href="https://identifiers.org/GO:0070091">GO:0070091 </a> | glucagon secretion | BiologicalProcess |
| <a href="https://identifiers.org/HP:0003074">HP:0003074 </a> | Hyperglycemia | PhenotypicFeature |
| <a href="https://identifiers.org/MESH:D003924">MESH:D003924 </a> | Diabetes Mellitus, Type 2 | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Linagliptin | NEGATIVELY REGULATES | Dipeptidyl Peptidase 4 |
| Dipeptidyl Peptidase 4 | NEGATIVELY REGULATES | Glucagon-Like Peptide 1 |
| Dipeptidyl Peptidase 4 | NEGATIVELY REGULATES | Gastric Inhibitory Polypeptide |
| Gastric Inhibitory Polypeptide | POSITIVELY REGULATES | Insulin Secretion |
| Gastric Inhibitory Polypeptide | NEGATIVELY REGULATES | Glucagon Secretion |
| Glucagon-Like Peptide 1 | POSITIVELY REGULATES | Insulin Secretion |
| Glucagon-Like Peptide 1 | NEGATIVELY REGULATES | Glucagon Secretion |
| Insulin Secretion | NEGATIVELY REGULATES | Hyperglycemia |
| Glucagon Secretion | POSITIVELY CORRELATED WITH | Hyperglycemia |
| Hyperglycemia | POSITIVELY CORRELATED WITH | Diabetes Mellitus, Type 2 |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB08882#mechanism-of-action](https://go.drugbank.com/drugs/DB08882#mechanism-of-action)
  - [https://en.wikipedia.org/wiki/Linagliptin](https://en.wikipedia.org/wiki/Linagliptin)
  - [https://www.uniprot.org/uniprot/P27487#function](https://www.uniprot.org/uniprot/P27487#function)
  - [https://www.uniprot.org/uniprot/P09681#function](https://www.uniprot.org/uniprot/P09681#function)
  - [https://en.wikipedia.org/wiki/Dipeptidyl_peptidase-4](https://en.wikipedia.org/wiki/Dipeptidyl_peptidase-4)
  - [https://en.wikipedia.org/wiki/Type_2_diabetes](https://en.wikipedia.org/wiki/Type_2_diabetes)
